During the past decade, LLC Uromed conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LLC Uromed" #1 sponsor was "Arena Pharmaceuticals" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LLC Uromed" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "CRO: iPharma" with 1 trials as a collaborator, "Government of the city of Moscow" with 1 trials as a collaborator and "Russian Direct Investment Fund" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "LLC Uromed" are "Ulcerative Colitis" (3 trials), "Chronic Rhinosinusitis" (2 trials), "Nasal Polyps" (2 trials), "COVID-19 Prevention" (1 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "LLC Uromed" in a lesser frequency.

Most popular intervention types in "LLC Uromed" are "Drug" (6 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Etrasimod" (3 trials), "Omalizumab" (2 trials), "Docetaxel" (1 trials) and "Erdafitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "LLC Uromed" are 7 trials for "All" genders.

Currently, there are NaN active trials in "LLC Uromed". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in LLC Uromed, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LLC Uromed, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".